首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>.

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>.

导出 OA

翻译打印收藏纠错

第一作者： Mark J,Levis

第一单位： Johns Hopkins University, Baltimore, MD.

作者： Mark J,Levis ^[1] ; Mehdi,Hamadani ^[2] ; Brent,Logan ^[2] ; Richard J,Jones ^[1] ; Anurag K,Singh ^[3] ; Mark,Litzow ^[4] ; John R,Wingard ^[5] ; Esperanza B,Papadopoulos ^[6] ; Alexander E,Perl ^[7] ; Robert J,Soiffer ^[8] ; Celalettin,Ustun ^[9] ; Masumi,Ueda Oshima ^[10] ; Geoffrey L,Uy ^[11] ; Edmund K,Waller ^[12] ; Sumithra,Vasu ^[13] ; Melhem,Solh ^[14] ; Asmita,Mishra ^[15] ; Lori,Muffly ^[16] ; Hee-Je,Kim ^[17] ; Jan-Henrik,Mikesch ^[18] ; Yuho,Najima ^[19] ; Masahiro,Onozawa ^[20] ; Kirsty,Thomson ^[21] ; Arnon,Nagler ^[22] ; Andrew H,Wei ^[23] ; Guido,Marcucci ^[24] ; Nancy L,Geller ^[25] ; Nahla,Hasabou ^[26] ; David,Delgado ^[26] ; Matt,Rosales ^[26] ; Jason,Hill ^[26] ; Stanley C,Gill ^[26] ; Rishita,Nuthethi ^[26] ; Denise,King ^[27] ; Heather,Wittsack ^[27] ; Adam,Mendizabal ^[27] ; Steven M,Devine ^[28] ; Mary M,Horowitz ^[2] ; Yi-Bin,Chen ^[29] ; BMT-CTN 1506/MORPHO Study Investigators

作者单位： Johns Hopkins University, Baltimore, MD. ^[1] CIBMTR/Medical College of Wisconsin, Milwaukee, WI. ^[2] University of Kansas, Kansas City, KS. ^[3] Mayo Clinic, Rochester, MN. ^[4] University of Florida, Gainesville, FL. ^[5] Memorial Sloan Kettering Cancer Center, New York, NY. ^[6] University of Pennsylvania, Philadelphia, PA. ^[7] Dana-Farber Cancer Institute, Boston, MA. ^[8] Rush University Medical Center, Chicago, IL. ^[9] Fred Hutchinson Cancer Center, Seattle, WA. ^[10] Washington University, St Louis, MO. ^[11] Emory University, Atlanta, GA. ^[12] Ohio State University, Columbus, OH. ^[13] Northside Hospital Cancer Institute, Atlanta, GA. ^[14] Moffitt Cancer Center, Tampa, FL. ^[15] Stanford University, Palo Alto, CA. ^[16] Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ^[17] University of Muenster, Münster, Germany. ^[18] Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. ^[19] Hokkaido University Hospital, Sapporo, Japan. ^[20] University College Hospital, London, United Kingdom. ^[21] Chaim Sheba Medical Center, Tel Hashomer, Israel. ^[22] Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Walter and Eliza Hill Institute of Medical Research and University of Melbourne, Melbourne, Australia. ^[23] Beckman Research Institute of City of Hope, Duarte, CA. ^[24] National Heart, Lung and Blood Institute, Bethesda, MD. ^[25] Astellas Pharma Inc, Northbrook, IL. ^[26] The Emmes Company, Rockville, MD. ^[27] National Marrow Donor Program, Minneapolis, MN. ^[28] Massachusetts General Hospital, Boston, MA. ^[29]